UA010833: A Novel Biomedical Target and Biomarker with Transformative Clinical Potential

Published by ANT BIO PTE. LTD.

Concept

UA010833 is a novel molecular marker and regulatory factor originally identified through large-scale genomic screening, mapped to human chromosome 7q31.2. It is expressed at low levels in healthy tissues but strongly upregulated in multiple diseases, including cancer, neurodegenerative disorders, and cardiovascular conditions. Acting as either a long non-coding RNA (lncRNA) or a structurally unique protein, UA010833 regulates epigenetic silencing, cell cycle checkpoints, metabolic signaling, and immune suppression. Its distinctive structure and disease-specific profile establish it as a highly promising target for diagnostics and drug development.

Research Frontiers

Recent studies have rapidly advanced understanding of UA010833 biology. Cryo-electron microscopy has revealed a rare “double-pocket” structural domain ideal for small-molecule targeting. Functional investigations show UA010833 recruits epigenetic modifiers such as DNMT3A, interacts strongly with the mTOR pathway (Kd = 3.2 nM), and accumulates specifically in myeloid-derived suppressor cells (MDSCs) in the tumor microenvironment. Single-cell transcriptomics and proteomics have further revealed its broad interaction network and role in therapy resistance.

Research Significance

UA010833 has emerged as a high-performance biomarker and therapeutic target with transformative clinical potential:

• Superior early detection of pancreatic cancer compared to CA19-9
• Predictive value for Alzheimer’s disease progression by correlating with tau pathology
• Strong association with coronary artery disease and major cardiovascular events
• High correlation with tumor drug resistance (r = 0.78)
• High druggability due to its unique structural architecture

These features support its use in precision diagnostics, prognostic monitoring, and novel therapeutic intervention.

Related Mechanisms and Research Applications

Biological Mechanisms

UA010833 functions through multiple interconnected pathways:

• Epigenetic repression by recruiting DNMT3A and silencing tumor suppressor genes including CDKN2A
• High-affinity binding to mTOR to modulate cellular metabolism and growth signaling
• Promotion of MDSC accumulation and immune suppression in tumors
• Regulation of cell cycle checkpoints and therapy resistance

Research Tools Supported by ANT BIO PTE. LTD.

Global researchers exploring UA010833 depend on reliable reagents provided by ANT BIO PTE. LTD.:

• Highly specific antibodies for detection, quantification, and neutralization
• Recombinant UA010833 proteins for structural and binding studies
• Custom ELISA kits for sensitive measurement in serum, CSF, and cell media
• Epigenetics and signaling reagents for functional pathway analysis

[Image Location: Genomic location, structural model, and functional signaling network of UA010833]

Brand Mission

ANT BIO PTE. LTD. empowers pioneering research in novel biomarkers and therapeutic targets by delivering high-quality, consistent life science reagents that accelerate discoveries in diagnostics, drug development, and personalized medicine.

Featured Related Products

表格

ANT BIO PTE. LTD. – Empowering Scientific Breakthroughs

At ANTBIO, we are committed to advancing life science research through high-quality, reliable reagents and comprehensive solutions. Our specialized sub-brands (Absin, Starter, UA) cover a full spectrum of research needs, from general reagents and kits to antibodies and recombinant proteins. With a focus on innovation, quality, and customer-centricity, we strive to be your trusted partner in unlocking scientific mysteries and driving medical progress. Explore our product portfolio today and elevate your research to new heights.